Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Parashar

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Oncoimmunology|June 14, 2013
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinomaSumit Agarwal, Shikha Saini, Deepak Parashar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 13, 2013
Expression and humoral response of A-kinase anchor protein 4 in cervical cancerSumit Agarwal, Shikha Saini, Deepak Parashar, et al.
Haematologica|July 13, 2023
IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myelomaMichael D Pisano, Fumou Sun, Yan Cheng, et al.
BMC Cancer|July 31, 2016
Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growthNirmala Jagadish, Deepak Parashar, Namita Gupta, et al.
BMC Cancer|March 1, 2018
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
JMIR Research Protocols|July 30, 2017
Integrated Care in Prostate Cancer (ICARE-P): Nonrandomized Controlled Feasibility Study of Online Holistic Needs Assessment, Linking the Patient and the Health Care TeamVeronica Nanton, Rebecca Appleton, Jeremy Dale, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
Oncogene|February 8, 2020
ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axisChangliang Chen, Prachi Gupta, Deepak Parashar, et al.
NPJ Precision Oncology|March 3, 2021
Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistanceDeepak Parashar, Anjali Geethadevi, Donna McAllister, et al.
Scientific Reports|April 14, 2016
Detection of colorectal dysplasia using fluorescently labelled lectinsJoe Chin-Hun Kuo, Ashraf E K Ibrahim, Sarah Dawson, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Oncoimmunology|June 14, 2013
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinomaSumit Agarwal, Shikha Saini, Deepak Parashar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 13, 2013
Expression and humoral response of A-kinase anchor protein 4 in cervical cancerSumit Agarwal, Shikha Saini, Deepak Parashar, et al.
Haematologica|July 13, 2023
IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myelomaMichael D Pisano, Fumou Sun, Yan Cheng, et al.
BMC Cancer|July 31, 2016
Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growthNirmala Jagadish, Deepak Parashar, Namita Gupta, et al.
BMC Cancer|March 1, 2018
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
JMIR Research Protocols|July 30, 2017
Integrated Care in Prostate Cancer (ICARE-P): Nonrandomized Controlled Feasibility Study of Online Holistic Needs Assessment, Linking the Patient and the Health Care TeamVeronica Nanton, Rebecca Appleton, Jeremy Dale, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
Oncogene|February 8, 2020
ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axisChangliang Chen, Prachi Gupta, Deepak Parashar, et al.
NPJ Precision Oncology|March 3, 2021
Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistanceDeepak Parashar, Anjali Geethadevi, Donna McAllister, et al.
Scientific Reports|April 14, 2016
Detection of colorectal dysplasia using fluorescently labelled lectinsJoe Chin-Hun Kuo, Ashraf E K Ibrahim, Sarah Dawson, et al.
Pageof 10